Analysis · Türkçe

Prediktif Fiyat Hassasiyeti Analizi: İlaç | Predictive Price Sensitivity Analysis: Pharma (TR)

Gerçek insanlar farklı klinik senaryolarda farklı katkı payı tutarlarına nasıl tepki veriyor?

Brox.AI· Published ·Also in 日本語, English
Who was asked
US patient clones, 900 clones
When
February 2026
How
Predicted responses from Brox clones, each built from a long-form interview with a real person, run on the Brox platform.
The full report Prediktif Fiyat Hassasiyeti Analizi: İlaç | Predictive Price Sensitivity Analysis: Pharma (TR) Open the report

Section 01: What the study found

  1. #

    7pp

    point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250)

    base 900

  2. #

    37pp

    point drop for a progressive but asymptomatic disease over the same copay range

    base 900

  3. #

    5%

    willingness once prior treatment failures compound with cost, from 30%

    base 900

Section 02: Where this sits

Ask this of your own customers: humans@brox.ai

More in Pharma & HCP

All in Pharma & HCP